amiodarone has been researched along with Wolff-Parkinson-White Syndrome in 90 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Wolff-Parkinson-White Syndrome: A form of ventricular pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave. In this syndrome, atrial impulses are abnormally conducted to the HEART VENTRICLES via an ACCESSORY CONDUCTING PATHWAY that is located between the wall of the right or left atria and the ventricles, also known as a BUNDLE OF KENT. The inherited form can be caused by mutation of PRKAG2 gene encoding a gamma-2 regulatory subunit of AMP-activated protein kinase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this review is to explore and challenge the superiority of amiodarone for rate control in Wolff-Parkinson-White syndrome and concomitant atrial fibrillation (WPW-AF)." | 8.86 | Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation. ( Langdorf, MI; Lotfipour, S; Simonian, SM; Wall, C, 2010) |
| "It was reported that intravenous amiodarone might induce ventricular fibrillation for acute treatment in patients with atrial fibrillation (AF) and Wolff-Parkinson-White (WPW) syndrome." | 8.02 | The use of intravenous amiodarone in patients with atrial fibrillation and Wolff-Parkinson-White syndrome. ( Ren, J; Shao, X; Wang, J; Wu, S; Yang, Y; Zhang, H; Zhu, J, 2021) |
| "We present a case of persistent fetal supraventricular tachycardia where transplacental and direct fetal treatment with amiodarone caused an iatrogenic hypothyroidism." | 7.69 | Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia. ( Bougatef, A; De Catte, L; De Schepper, J; De Wolf, D; Foulon, W; Smitz, J, 1994) |
| "Amiodarone-induced chemical, sterile epididymitis has previously been reported." | 7.69 | Amiodarone-induced epididymitis. Report of 2 cases. ( Hamoud, K; Kaneti, J; Lissmer, L; Smailowitz, Z, 1996) |
| "Amiodarone resulted in a rapid ventricular response to atrial flutter in an infant with Wolff-Parkinson-White syndrome." | 7.68 | Acceleration of the ventricular response to atrial flutter by amiodarone in an infant with Wolff-Parkinson-White syndrome. ( Baxendall, M; Benetar, A; Till, JA, 1993) |
| "In a 20-year-old patient with Marfan's syndrome and Wolff-Parkinson-White syndrome, effective amiodarone treatment had to be stopped due to serious hyperthyroidism." | 7.67 | Amiodarone-induced hyperthyroidism in a patient with Marfan's syndrome and Wolff-Parkinson-White syndrome. ( Hazenberg, HJ; Tietge, FC, 1985) |
| "The clinical and electrophysiologic effects of oral amiodarone were evaluated in 10 patients with a history of spontaneous atrial fibrillation and a rapid ventricular response, complicating the Wolff-Parkinson-White syndrome." | 7.67 | Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome. ( Feld, GK; Klitzner, T; Nademanee, K; Singh, BN; Stevenson, W; Weiss, J, 1988) |
| "We observed a dangerous increase of ventricular rate following the intravenous administration of amiodarone in a patient with atrial fibrillation and rapid ventricular response associated with the Wolff-Parkinson-White syndrome." | 7.67 | Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case report. ( Gmeiner, R; Leisch, F; Schützenberger, W, 1987) |
| "In order to control a re-entrant tachycardia in a patient with Wolff-Parkinson-White syndrome, intravenous Amiodarone (5 mg/Kg per min." | 7.67 | [Possible danger of rapid intravenous amiodarone in re-entry tachycardia in subjects with Wolff-Parkinson-White syndrome]. ( Auricchio, A; De Stefano, R; Vitale, P, 1986) |
| "Oral amiodarone was administered to ten children aged 3 months to 15 years who had recurrent SVT associated with the Wolff-Parkinson-White syndrome." | 7.66 | Amiodarone in control of sustained tachyarrhythmias in children with Wolff-Parkinson-White syndrome. ( Barzilay, Z; Feigl, A; Frand, M; Shahar, E, 1983) |
| "Oral amiodarone has been used to treat 21 patients with various supraventricular arrhythmias; 13 had Wolff-Parkinson-White syndrome, which was complicated by atrial fibrillation and re-entry atrioventricular tachycardia in four, and re-entry tachycardia alone in the other nine." | 7.66 | Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias. ( Krikler, DM; Rowland, E, 1980) |
| "In patients with the Wolff-Parkinson-White syndrome, intravenous ajmaline (50 mg administered over 3 minutes) or procainamide (10 mg/kg body weight administered over 10 minutes) is helpful in defining the duration of the anterograde effective refractory period of the accessory pathway." | 7.66 | Value of the ajmaline-procainamide test to predict the effect of long-term oral amiodarone on the anterograde effective refractory period of the accessory pathway in the Wolff-Parkinson-White syndrome. ( Braat, S; Brugada, P; Dassen, WR; Gorgels, AP; Wellens, HJ, 1983) |
| "Amiodarone was utilized in 70 patients with symptomatic, sustained refractory tachyarrhythmias." | 7.66 | Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias. ( Lown, B; Podrid, PJ, 1981) |
| "Amiodarone was used in 30 patients with tachyarrhythmias refractory to treatment with several antiarrhythmic agents." | 7.66 | Amiodarone in long term management of refractory cardiac tachyarrhythmias. ( Lowe, JB; Lubbe, WF; Mercer, CJ; Roche, AH, 1981) |
| "Amiodarone was used in 40 patients with life-threatening or refractory tachyarrhythmias." | 7.66 | Amiodarone therapy for life threatening or refractory cardiac arrhythmias. ( Anderson, ST; Currie, PJ; Federman, J; Harper, RW; Johns, JA; Pitt, A, 1983) |
| "The effect of amiodarone in the Wolff-Parkinson-White syndrome was studied with programmed electrical stimulation of the heart in 15 patients." | 7.65 | Effect of amiodarone in the Wolff-Parkinson-White syndrome. ( Bär, FW; Dohmen, HJ; Düren, DR; Durrer, D; Lie, KI; Wellens, HJ; Wesdorp, JC, 1976) |
| "When amiodarone treatment had become clinically effective, a second comparative study was made in four patients after 26--85 days' treatment." | 6.65 | Effect of amiodarone in the Wolff-Parkinson-White syndrome. A clinical and electrophysiological study. ( Berning, J; Rasmussen, V, 1979) |
| "Nine had overt, and 6 had concealed WPW syndrome." | 5.30 | Effect of intravenous amiodarone on electrophysiologic variables and on the modes of termination of atrioventricular reciprocating tachycardia in Wolff-Parkinson-White syndrome. ( Kuga, K; Sugishita, Y; Yamaguchi, I, 1999) |
| "Propafenone was less effective (mean effect 3." | 5.27 | European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias. ( Assayag, P; Coumel, P; Leclercq, JF, 1984) |
| "Thus, the safety of amiodarone in the WPW syndrome should be established by electrophysiologic studies and induction of AF, because amiodarone is not protective in all patients with WPW." | 5.27 | Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation. ( Fromer, MA; Kappenberger, LJ; Shenasa, M; Steinbrunn, W, 1984) |
| "Amiodarone is an anti-arrhythmic drug with a content of 39% Iodine." | 5.27 | Congenital hypothyroid goiter and amiodarone. ( De Schepper, J; De Wolf, D; Deneyer, M; Sacre-Smits, L; Smitz, J; Verhaaren, H, 1988) |
| "During AF in WPW syndrome, the ventricular rate is related to the duration of the anterograde refractory period of the accessory pathway." | 5.27 | Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome. ( Abdollah, H; Brugada, P; Wellens, HJ, 1983) |
| "The objective of this review is to explore and challenge the superiority of amiodarone for rate control in Wolff-Parkinson-White syndrome and concomitant atrial fibrillation (WPW-AF)." | 4.86 | Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation. ( Langdorf, MI; Lotfipour, S; Simonian, SM; Wall, C, 2010) |
| "It was reported that intravenous amiodarone might induce ventricular fibrillation for acute treatment in patients with atrial fibrillation (AF) and Wolff-Parkinson-White (WPW) syndrome." | 4.02 | The use of intravenous amiodarone in patients with atrial fibrillation and Wolff-Parkinson-White syndrome. ( Ren, J; Shao, X; Wang, J; Wu, S; Yang, Y; Zhang, H; Zhu, J, 2021) |
| "We present a case of persistent fetal supraventricular tachycardia where transplacental and direct fetal treatment with amiodarone caused an iatrogenic hypothyroidism." | 3.69 | Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia. ( Bougatef, A; De Catte, L; De Schepper, J; De Wolf, D; Foulon, W; Smitz, J, 1994) |
| "Amiodarone-induced chemical, sterile epididymitis has previously been reported." | 3.69 | Amiodarone-induced epididymitis. Report of 2 cases. ( Hamoud, K; Kaneti, J; Lissmer, L; Smailowitz, Z, 1996) |
| "Amiodarone resulted in a rapid ventricular response to atrial flutter in an infant with Wolff-Parkinson-White syndrome." | 3.68 | Acceleration of the ventricular response to atrial flutter by amiodarone in an infant with Wolff-Parkinson-White syndrome. ( Baxendall, M; Benetar, A; Till, JA, 1993) |
| "In a 20-year-old patient with Marfan's syndrome and Wolff-Parkinson-White syndrome, effective amiodarone treatment had to be stopped due to serious hyperthyroidism." | 3.67 | Amiodarone-induced hyperthyroidism in a patient with Marfan's syndrome and Wolff-Parkinson-White syndrome. ( Hazenberg, HJ; Tietge, FC, 1985) |
| "In 12 patients (nine with Wolff-Parkinson-White syndrome and three with ventricular tachycardia) the electrophysiologic effects of intravenous (5 mg/kg body weight in 1 min) and oral (total dose 9800 to 11,200 mg) amiodarone were studied with programmed stimulation of the heart." | 3.67 | A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient. ( Abdollah, H; Brugada, P; Dassen, WR; Wellens, HJ, 1984) |
| "The clinical and electrophysiologic effects of oral amiodarone were evaluated in 10 patients with a history of spontaneous atrial fibrillation and a rapid ventricular response, complicating the Wolff-Parkinson-White syndrome." | 3.67 | Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome. ( Feld, GK; Klitzner, T; Nademanee, K; Singh, BN; Stevenson, W; Weiss, J, 1988) |
| "In order to control a re-entrant tachycardia in a patient with Wolff-Parkinson-White syndrome, intravenous Amiodarone (5 mg/Kg per min." | 3.67 | [Possible danger of rapid intravenous amiodarone in re-entry tachycardia in subjects with Wolff-Parkinson-White syndrome]. ( Auricchio, A; De Stefano, R; Vitale, P, 1986) |
| "We observed a dangerous increase of ventricular rate following the intravenous administration of amiodarone in a patient with atrial fibrillation and rapid ventricular response associated with the Wolff-Parkinson-White syndrome." | 3.67 | Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case report. ( Gmeiner, R; Leisch, F; Schützenberger, W, 1987) |
| "This study was performed to ascertain whether intravenous amiodarone would revert supraventricular tachycardias to sinus rhythm, and if so, whether this effect depended upon the underlying mechanism of the arrhythmia." | 3.67 | Intravenous amiodarone in the acute termination of supraventricular arrhythmias. ( Crick, JC; Curry, P; Davies, DW; Holt, P, 1985) |
| "Amiodarone has proved to be a valuable drug in atrial fibrillation associated with the Wolff-Parkinson-White syndrome." | 3.66 | Acceleration of ventricular rate by fibrillation associated with the Wolff-Parkinson-White syndrome. ( Evans, T; Sheinman, BD, 1982) |
| "An esophageal lead was used to perform decremental atrial pacing and elective induction of atrial fibrillation (AF) in 5 patients with the Wolff-Parkinson-White (W-P-W) syndrome before and after amiodarone therapy." | 3.66 | Transesophageal pacing for prognostic evaluation of preexcitation syndrome and assessment of protective therapy. ( Coltorti, F; Condorelli, M; Critelli, G; Grassi, G; Monda, V; Perticone, F, 1983) |
| "A patient with types A and B of Wolff-Parkinson-White syndrome developed subacute pneumonitis during long-term treatment with amiodarone." | 3.66 | Subacute pneumopathy during amiodarone therapy. ( Bellotti, M; Bunster, AM; Elsner, B; Esteva, H; Poderoso, JJ; Suárez, LD, 1983) |
| "Amiodarone was utilized in 70 patients with symptomatic, sustained refractory tachyarrhythmias." | 3.66 | Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias. ( Lown, B; Podrid, PJ, 1981) |
| "In patients with the Wolff-Parkinson-White syndrome, intravenous ajmaline (50 mg administered over 3 minutes) or procainamide (10 mg/kg body weight administered over 10 minutes) is helpful in defining the duration of the anterograde effective refractory period of the accessory pathway." | 3.66 | Value of the ajmaline-procainamide test to predict the effect of long-term oral amiodarone on the anterograde effective refractory period of the accessory pathway in the Wolff-Parkinson-White syndrome. ( Braat, S; Brugada, P; Dassen, WR; Gorgels, AP; Wellens, HJ, 1983) |
| "Amiodarone was used in 30 patients with tachyarrhythmias refractory to treatment with several antiarrhythmic agents." | 3.66 | Amiodarone in long term management of refractory cardiac tachyarrhythmias. ( Lowe, JB; Lubbe, WF; Mercer, CJ; Roche, AH, 1981) |
| "Arrhythmias may be controlled in most patients with recurrent supraventricular tachycardia or atrial fibrillation with small to moderate maintenance doses of amiodarone (100 to 400 mg/day)." | 3.66 | Ten years of experience with amiodarone. ( Chiale, PA; Elizari, MV; Haedo, A; Lázzari, JO; Rosenbaum, MB, 1983) |
| "Oral amiodarone has been used to treat 21 patients with various supraventricular arrhythmias; 13 had Wolff-Parkinson-White syndrome, which was complicated by atrial fibrillation and re-entry atrioventricular tachycardia in four, and re-entry tachycardia alone in the other nine." | 3.66 | Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias. ( Krikler, DM; Rowland, E, 1980) |
| "Amiodarone was used in 40 patients with life-threatening or refractory tachyarrhythmias." | 3.66 | Amiodarone therapy for life threatening or refractory cardiac arrhythmias. ( Anderson, ST; Currie, PJ; Federman, J; Harper, RW; Johns, JA; Pitt, A, 1983) |
| "Oral amiodarone was administered to ten children aged 3 months to 15 years who had recurrent SVT associated with the Wolff-Parkinson-White syndrome." | 3.66 | Amiodarone in control of sustained tachyarrhythmias in children with Wolff-Parkinson-White syndrome. ( Barzilay, Z; Feigl, A; Frand, M; Shahar, E, 1983) |
| "The effect of amiodarone in the Wolff-Parkinson-White syndrome was studied with programmed electrical stimulation of the heart in 15 patients." | 3.65 | Effect of amiodarone in the Wolff-Parkinson-White syndrome. ( Bär, FW; Dohmen, HJ; Düren, DR; Durrer, D; Lie, KI; Wellens, HJ; Wesdorp, JC, 1976) |
| "When amiodarone treatment had become clinically effective, a second comparative study was made in four patients after 26--85 days' treatment." | 2.65 | Effect of amiodarone in the Wolff-Parkinson-White syndrome. A clinical and electrophysiological study. ( Berning, J; Rasmussen, V, 1979) |
| "Eight patients with WPW syndrome were catheterised and, during the course of this investigation, the electrophysiological effects of amiodarone were assessed." | 2.64 | [Electrophysiologic effects of amiodarone in Wolf-Parkinson-White syndrome]. ( Delahaye, JP; Huerta, F; Porte, J; Touboul, P, 1976) |
| " Little justification for the use of agents or dosing in children is available." | 2.40 | Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry. ( Kuhn, RJ; Luedtke, SA; McCaffrey, FM, 1997) |
| "Amiodarone has a reduced clearance rate, large volume of distribution, low bioavailability and a long half-life that may last 2 months in patients receiving short-term therapy." | 2.37 | Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects. ( Heger, JJ; Prystowsky, EN; Zipes, DP, 1984) |
| "The management of ventricular tachycardia depends on clinical symptoms and is influenced by the presence of structural heart disease." | 1.37 | Electrocardiography Series. What is the cause of the regular wide QRS complex tachycardia? ( Kireyev, D; Lim, SL; Poh, KK; Teo, SG, 2011) |
| "Nine had overt, and 6 had concealed WPW syndrome." | 1.30 | Effect of intravenous amiodarone on electrophysiologic variables and on the modes of termination of atrioventricular reciprocating tachycardia in Wolff-Parkinson-White syndrome. ( Kuga, K; Sugishita, Y; Yamaguchi, I, 1999) |
| "Supraventricular tachycardia is one of the most frequent arrhythmias in childhood." | 1.27 | [Supraventricular tachycardia in children]. ( Attanà, A; Battaglia, T; Caristo, S; Ciconte, V; Fumarulo, A; Martini, B; Paparo, F, 1983) |
| "Association of long QT with arrhythmia does not, therefore, invalidate the principle that homogeneously prolonged APD should be anti-arrhythmic." | 1.27 | Delayed ventricular repolarization as an anti-arrhythmic principle. ( Vaughan Williams, EM, 1985) |
| "During AF in WPW syndrome, the ventricular rate is related to the duration of the anterograde refractory period of the accessory pathway." | 1.27 | Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome. ( Abdollah, H; Brugada, P; Wellens, HJ, 1983) |
| "Thus, the safety of amiodarone in the WPW syndrome should be established by electrophysiologic studies and induction of AF, because amiodarone is not protective in all patients with WPW." | 1.27 | Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation. ( Fromer, MA; Kappenberger, LJ; Shenasa, M; Steinbrunn, W, 1984) |
| "Amiodarone is an anti-arrhythmic drug with a content of 39% Iodine." | 1.27 | Congenital hypothyroid goiter and amiodarone. ( De Schepper, J; De Wolf, D; Deneyer, M; Sacre-Smits, L; Smitz, J; Verhaaren, H, 1988) |
| "Verapamil was more effective due to the immediate response and lack of adverse effects." | 1.27 | Pre-excitation syndrome in infants and children. Effect of digoxin, verapamil, and amiodarone. ( Barzilay, Z; Frand, M; Shahar, E; Shem-Tov, AA; Shohet, I, 1983) |
| "Propafenone was less effective (mean effect 3." | 1.27 | European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias. ( Assayag, P; Coumel, P; Leclercq, JF, 1984) |
| "Type 2 tachycardia was of the slow-fast A-V nodal pathway type." | 1.26 | Quintuple pathways participating in three distinct types of atrioventricular reciprocating tachycardia in a patient with Wolff-Parkinson-White syndrome. ( Castellanos, A; Portillo, B; Portillo-Leon, N; Zaman, L, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 67 (74.44) | 18.7374 |
| 1990's | 12 (13.33) | 18.2507 |
| 2000's | 4 (4.44) | 29.6817 |
| 2010's | 6 (6.67) | 24.3611 |
| 2020's | 1 (1.11) | 2.80 |
| Authors | Studies |
|---|---|
| Ren, J | 1 |
| Yang, Y | 1 |
| Zhu, J | 1 |
| Wu, S | 1 |
| Wang, J | 1 |
| Zhang, H | 1 |
| Shao, X | 1 |
| Cadrin-Tourigny, J | 1 |
| Fournier, A | 1 |
| Andelfinger, G | 1 |
| Khairy, P | 1 |
| Bodalski, R | 1 |
| Maryniak, A | 1 |
| Walczak, F | 1 |
| Szumowski, L | 1 |
| Jedynak, Z | 1 |
| Simonian, SM | 1 |
| Lotfipour, S | 1 |
| Wall, C | 1 |
| Langdorf, MI | 1 |
| Maheshwari, M | 1 |
| Mittal, SR | 1 |
| Brace, S | 1 |
| Lim, SL | 1 |
| Teo, SG | 1 |
| Kireyev, D | 1 |
| Poh, KK | 1 |
| Trombert, V | 1 |
| Samaras, N | 1 |
| Willich, T | 1 |
| Hammwöhner, M | 1 |
| Goette, A | 1 |
| Ozaydín, M | 1 |
| Varol, E | 1 |
| Dogan, A | 1 |
| Aslan, SM | 1 |
| Altínbas, A | 1 |
| Negro, R | 1 |
| Aloisi, B | 1 |
| Russo, L | 1 |
| Mazzaglia, G | 1 |
| Liistro, M | 1 |
| Brancati, B | 1 |
| Prystowsky, EN | 2 |
| Coumel, P | 2 |
| Leclercq, JF | 1 |
| Assayag, P | 1 |
| Zipes, DP | 2 |
| Heger, JJ | 1 |
| Kappenberger, LJ | 1 |
| Fromer, MA | 1 |
| Steinbrunn, W | 1 |
| Shenasa, M | 1 |
| Vergara de Campos, A | 1 |
| Otero Chulián, E | 1 |
| González Martínez, V | 1 |
| Cardenete Ibañez, F | 1 |
| Rico Irles, J | 1 |
| Dick, M | 1 |
| Campbell, RM | 1 |
| Johns, JA | 1 |
| Harper, RW | 1 |
| Currie, PJ | 1 |
| Federman, J | 1 |
| Anderson, ST | 1 |
| Pitt, A | 1 |
| Wellens, HJ | 8 |
| Brugada, P | 6 |
| Abdollah, H | 2 |
| Rosenbaum, MB | 4 |
| Chiale, PA | 4 |
| Haedo, A | 1 |
| Lázzari, JO | 2 |
| Elizari, MV | 4 |
| Shahar, E | 2 |
| Barzilay, Z | 2 |
| Frand, M | 2 |
| Feigl, A | 1 |
| Hesslein, PS | 1 |
| Battaglia, T | 1 |
| Paparo, F | 1 |
| Fumarulo, A | 1 |
| Attanà, A | 1 |
| Ciconte, V | 1 |
| Caristo, S | 1 |
| Martini, B | 1 |
| Dassen, WR | 3 |
| Feld, GK | 2 |
| Nademanee, K | 2 |
| Weiss, J | 2 |
| Stevenson, W | 2 |
| Singh, BN | 2 |
| Heddle, WF | 1 |
| Garabedian, V | 1 |
| Lagarde, O | 1 |
| Guiraudon, C | 1 |
| Frank, F | 1 |
| Fontaine, G | 1 |
| Richart, JC | 1 |
| Coignard, A | 1 |
| Duret, JC | 1 |
| Mardelle, T | 1 |
| Droniou, J | 1 |
| Sheinman, BD | 1 |
| Evans, T | 1 |
| Critelli, G | 1 |
| Grassi, G | 1 |
| Perticone, F | 3 |
| Coltorti, F | 1 |
| Monda, V | 2 |
| Condorelli, M | 1 |
| Suárez, LD | 1 |
| Poderoso, JJ | 1 |
| Elsner, B | 1 |
| Bunster, AM | 1 |
| Esteva, H | 1 |
| Bellotti, M | 1 |
| Shem-Tov, AA | 1 |
| Shohet, I | 1 |
| Braat, S | 1 |
| Gorgels, AP | 1 |
| Lubbe, WF | 1 |
| Mercer, CJ | 1 |
| Roche, AH | 1 |
| Lowe, JB | 1 |
| Marcus, FI | 1 |
| Fontaine, GH | 1 |
| Frank, R | 1 |
| Grosgogeat, Y | 1 |
| Lukoshevichiute, AI | 1 |
| Reĭngardene, DI | 1 |
| Portillo, B | 1 |
| Portillo-Leon, N | 1 |
| Zaman, L | 1 |
| Castellanos, A | 1 |
| Podrid, PJ | 1 |
| Lown, B | 1 |
| Przybylski, J | 3 |
| Halpern, MS | 2 |
| Nau, GJ | 1 |
| Bär, FW | 2 |
| Vanagt, EJ | 1 |
| Farré, J | 1 |
| Rowland, E | 2 |
| Krikler, DM | 2 |
| Ward, DE | 1 |
| Camm, AJ | 1 |
| Spurrell, RA | 1 |
| Chia, BL | 1 |
| Teo, WS | 1 |
| Agnant, RA | 1 |
| Louis, R | 1 |
| Bury, T | 1 |
| Radermecker, MF | 1 |
| Moro Serrano, C | 1 |
| Hernández Madrid, A | 1 |
| Lage Silveira, J | 1 |
| Vivas Alvarez, E | 1 |
| Kanjhi, M | 1 |
| De Catte, L | 1 |
| De Wolf, D | 2 |
| Smitz, J | 2 |
| Bougatef, A | 1 |
| De Schepper, J | 2 |
| Foulon, W | 1 |
| Till, JA | 1 |
| Baxendall, M | 1 |
| Benetar, A | 1 |
| Chen, SA | 1 |
| Chiang, CE | 1 |
| Tai, CT | 1 |
| Lee, SH | 1 |
| Chiou, CW | 1 |
| Ueng, KC | 1 |
| Wen, ZC | 1 |
| Cheng, CC | 1 |
| Chang, MS | 1 |
| Boriani, G | 1 |
| Biffi, M | 1 |
| Frabetti, L | 1 |
| Azzolini, U | 1 |
| Sabbatani, P | 1 |
| Bronzetti, G | 1 |
| Capucci, A | 1 |
| Magnani, B | 1 |
| Hamoud, K | 1 |
| Kaneti, J | 1 |
| Smailowitz, Z | 1 |
| Lissmer, L | 1 |
| Luedtke, SA | 1 |
| Kuhn, RJ | 1 |
| McCaffrey, FM | 1 |
| Gómez-Barrado, JJ | 1 |
| García-Rubira, JC | 1 |
| Turégano Albarrán, S | 1 |
| Pavón García, M | 1 |
| Hidalgo Urbano, R | 1 |
| Montes Ramírez, JM | 1 |
| Cruz Fernández, JM | 1 |
| Matiushin, GV | 1 |
| Shul'man, VA | 1 |
| Balog, AI | 1 |
| Golovenkin, SE | 1 |
| Bezruk, AP | 1 |
| Ivanitskiĭ, EA | 1 |
| Smirnova, OV | 1 |
| Kuga, K | 1 |
| Yamaguchi, I | 1 |
| Sugishita, Y | 1 |
| Trohman, RG | 1 |
| Preobrazhenskiĭ, DV | 1 |
| Ryndina, MG | 1 |
| Blizniak, GV | 1 |
| Curry, PV | 1 |
| Krikler, D | 1 |
| Rosen, MR | 1 |
| Waleffe, A | 1 |
| Bruninx, P | 1 |
| Kulbertus, HE | 1 |
| Rasmussen, V | 1 |
| Berning, J | 1 |
| Cosma, C | 1 |
| Crepin, D | 1 |
| Py, J | 1 |
| Bennett, DH | 1 |
| Gribbin, B | 1 |
| Birkhead, JS | 1 |
| Chamberlain, DA | 1 |
| Clark, AN | 1 |
| Barbosa Lopes, AA | 1 |
| Scalabrini Neto, A | 1 |
| Barbosa, SA | 1 |
| Tranchesi, J | 1 |
| Gronda, M | 1 |
| Rognoni, G | 1 |
| Rossi, P | 1 |
| Touboul, P | 1 |
| Porte, J | 1 |
| Huerta, F | 1 |
| Delahaye, JP | 1 |
| Lie, KI | 1 |
| Wesdorp, JC | 1 |
| Dohmen, HJ | 1 |
| Düren, DR | 1 |
| Durrer, D | 1 |
| Quinteiro, RA | 1 |
| Vaughan Williams, EM | 1 |
| Tuzcu, EM | 1 |
| Gilbo, J | 1 |
| Masterson, M | 1 |
| Maloney, JD | 1 |
| Casciani, M | 1 |
| Podestà, M | 1 |
| Carolis, S | 1 |
| Bargellini, F | 1 |
| Anticoli Borza, S | 1 |
| Dewachter, A | 1 |
| Lievens, H | 1 |
| Klitzner, T | 1 |
| Verhaaren, H | 1 |
| Deneyer, M | 1 |
| Sacre-Smits, L | 1 |
| Depelchin, P | 1 |
| Schoenfeld, P | 1 |
| Stoupel, E | 1 |
| Degré, S | 1 |
| Vitale, P | 1 |
| De Stefano, R | 1 |
| Auricchio, A | 1 |
| Shepherd, NA | 1 |
| Dawson, AM | 1 |
| Crocker, PR | 1 |
| Levison, DA | 1 |
| Schützenberger, W | 1 |
| Leisch, F | 1 |
| Gmeiner, R | 1 |
| Cuda, G | 1 |
| Spadea, F | 2 |
| Pintaudi, C | 2 |
| Tropea, R | 2 |
| Adinolfi, L | 1 |
| Golia, B | 1 |
| Montano, A | 1 |
| Romano, M | 1 |
| Maione, S | 1 |
| Chiacchio, T | 1 |
| Mazza, F | 1 |
| Columbro, C | 1 |
| Bova, G | 1 |
| Jaeger, M | 1 |
| Santos, MA | 1 |
| Simões, LC | 1 |
| Liu, PH | 1 |
| Lin, CC | 1 |
| Ko, GC | 1 |
| Wang, DJ | 1 |
| Shieh, SM | 1 |
| Sung, PK | 1 |
| Gonzalez, MD | 1 |
| Guillen, RH | 1 |
| Pellizzon, OA | 1 |
| Raimondi, EC | 1 |
| Holt, P | 1 |
| Crick, JC | 1 |
| Davies, DW | 1 |
| Curry, P | 1 |
| Penn, IM | 1 |
| Barrett, PA | 1 |
| Pannikote, V | 1 |
| Barnaby, PF | 1 |
| Campbell, JB | 1 |
| Lyons, NR | 1 |
| Hazenberg, HJ | 1 |
| Tietge, FC | 1 |
| Yagupsky, P | 1 |
| Gazala, E | 1 |
| Sofer, S | 1 |
| Maor, E | 1 |
| Abarbanel, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| aMsa and amiOdarone Study in cArdiaC Arrest[NCT04997980] | 500 participants (Anticipated) | Observational | 2015-01-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for amiodarone and Wolff-Parkinson-White Syndrome
| Article | Year |
|---|---|
Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Emergency Servi | 2010 |
[Therapy of atrial fibrillation in the critically ill].
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Comorbidity; Contraindicati | 2012 |
Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ajmaline; Amiodarone; Anilides; Aprindine; Atr | 1983 |
Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects.
Topics: Administration, Oral; Amiodarone; Animals; Arrhythmias, Cardiac; Atrioventricular Node; Benzofurans; | 1984 |
Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone.
Topics: Acute Disease; Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atria | 1981 |
[Value of drug tests in Wolff-Parkinson-White syndrome].
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrioventricular Node; Diagnosis, Differential; Electr | 1981 |
[Amiodarone in the nineties: to whom and what dosage?].
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Hypertrophic; Clinical Trials | 1995 |
Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Calcium Channel Blockers; Child; Ch | 1997 |
Supraventricular tachycardia: implications for the intensivist.
Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Electrocardiogra | 2000 |
[Clinical use of Cordarone].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhyth | 1979 |
[Amiodarone, a class 3 antiarrhythmic agent: current electrophysiological and therapeutic aspects].
Topics: Administration, Oral; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiomyopathy, Hypertrophic; H | 1986 |
3 trials available for amiodarone and Wolff-Parkinson-White Syndrome
| Article | Year |
|---|---|
[Clinical use of Cordarone].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhyth | 1979 |
Effect of amiodarone in the Wolff-Parkinson-White syndrome. A clinical and electrophysiological study.
Topics: Adult; Aged; Amiodarone; Benzofurans; Bundle of His; Cardiac Pacing, Artificial; Clinical Trials as | 1979 |
[Electrophysiologic effects of amiodarone in Wolf-Parkinson-White syndrome].
Topics: Action Potentials; Adult; Amiodarone; Anti-Arrhythmia Agents; Benzofurans; Bundle of His; Clinical T | 1976 |
77 other studies available for amiodarone and Wolff-Parkinson-White Syndrome
| Article | Year |
|---|---|
The use of intravenous amiodarone in patients with atrial fibrillation and Wolff-Parkinson-White syndrome.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Humans; Infusions, Intravenous; Mal | 2021 |
Severe left ventricular dysfunction in infants with ventricular preexcitation.
Topics: Adrenergic alpha-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, Dilate | 2008 |
[Glass of water or ablation? - episodes of malignant atrial tachyarrhythmias during swimming in a lake in a woman with overt Wolff-Parkinson-White syndrome and benign palpitations for several decades of life].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter | 2008 |
Wolff-Parkinson-White syndrome and rheumatic mitral stenosis--an uncommon association.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Diuretics; Electrocardiography; Humans; Male; Mi | 2010 |
Emergency treatment of Wolff-Parkinson-White syndrome.
Topics: Amiodarone; Anti-Arrhythmia Agents; Causality; Electric Countershock; Electrocardiography; Emergency | 2011 |
Electrocardiography Series. What is the cause of the regular wide QRS complex tachycardia?
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Bundle-Branch Block; Cardiology; Diagnosis, D | 2011 |
[Practical problem on ECG in elderly patient. Case #18].
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Electrocardiography; | 2011 |
Multiple tachycardia forms occurring in a patient with Wolff-Parkinson-White syndrome and acute myocardial infarction.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiotonic Agents; Dopamine; Drug Therapy, | 2007 |
[Long-term use of amiodarone in the treatment of ventricular pre-excitation with tachyarrhythmia attacks].
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Benzofurans; Drug Therapy, Combination; Humans; Q | 1981 |
European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillati | 1984 |
Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation.
Topics: Adolescent; Adult; Amiodarone; Atrial Fibrillation; Benzofurans; Cardiac Pacing, Artificial; Electro | 1984 |
[Electrophysiologic study of pre-excitation syndromes in our environment (V)].
Topics: Amiodarone; Cardiac Catheterization; Electrocardiography; Heart Conduction System; Humans; Wolff-Par | 1984 |
Advances in the management of cardiac arrhythmias in children.
Topics: Adolescent; Adult; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Pa | 1984 |
Amiodarone therapy for life threatening or refractory cardiac arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Kinetics; Ma | 1983 |
Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome.
Topics: Ajmaline; Amiodarone; Atrial Fibrillation; Benzofurans; Electrophysiology; Heart; Humans; Isoprotere | 1983 |
Ten years of experience with amiodarone.
Topics: Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Chagas Cardiomyopathy; Dose-Resp | 1983 |
Amiodarone in control of sustained tachyarrhythmias in children with Wolff-Parkinson-White syndrome.
Topics: Administration, Oral; Adolescent; Amiodarone; Benzofurans; Child; Child, Preschool; Electrocardiogra | 1983 |
Amiodarone therapy in children: a cautionary comment.
Topics: Adolescent; Amiodarone; Benzofurans; Child; Child, Preschool; Humans; Infant; Tachycardia; Wolff-Par | 1983 |
[Supraventricular tachycardia in children].
Topics: Adenosine Triphosphate; Amiodarone; Cardiac Pacing, Artificial; Child; Digitalis Glycosides; Heart D | 1983 |
A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient.
Topics: Administration, Oral; Adolescent; Adult; Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Child; | 1984 |
Electrophysiologic basis for the suppression by amiodarone of orthodromic supraventricular tachycardias complicating pre-excitation syndromes.
Topics: Adult; Aged; Amiodarone; Benzofurans; Digoxin; Electrocardiography; Heart Conduction System; Humans; | 1984 |
Multiple circus movement tachycardias with multiple accessory pathways.
Topics: Amiodarone; Atrioventricular Node; Cardiac Pacing, Artificial; Child; Electrocardiography; Female; H | 1984 |
[Malignant ventricular tachyarrythmia due to atrial fibrillation in the Wolff-Parkinson-White syndrome. Section of the Kent bundle apropos of 2 cases].
Topics: Adult; Amiodarone; Atrial Fibrillation; Electrocardiography; Electrophysiology; Heart Conduction Sys | 1981 |
Acceleration of ventricular rate by fibrillation associated with the Wolff-Parkinson-White syndrome.
Topics: Aged; Amiodarone; Atrial Fibrillation; Benzofurans; Electrocardiography; Humans; Male; Tachycardia; | 1982 |
Transesophageal pacing for prognostic evaluation of preexcitation syndrome and assessment of protective therapy.
Topics: Adolescent; Adult; Amiodarone; Atrial Fibrillation; Cardiac Pacing, Artificial; Death, Sudden; Esoph | 1983 |
Subacute pneumopathy during amiodarone therapy.
Topics: Amiodarone; Benzofurans; Female; Humans; Lung; Middle Aged; Pneumonia; Wolff-Parkinson-White Syndrom | 1983 |
Pre-excitation syndrome in infants and children. Effect of digoxin, verapamil, and amiodarone.
Topics: Adolescent; Amiodarone; Child; Child, Preschool; Digoxin; Electrocardiography; Humans; Infant; Infan | 1983 |
Value of the ajmaline-procainamide test to predict the effect of long-term oral amiodarone on the anterograde effective refractory period of the accessory pathway in the Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Ajmaline; Amiodarone; Benzofurans; Electrophysiology; Female; Heart Conduction Sy | 1983 |
Amiodarone in long term management of refractory cardiac tachyarrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Female; Heart Atria | 1981 |
Quintuple pathways participating in three distinct types of atrioventricular reciprocating tachycardia in a patient with Wolff-Parkinson-White syndrome.
Topics: Aged; Amiodarone; Atrioventricular Node; Electrocardiography; Electrophysiology; Heart Conduction Sy | 1982 |
Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Male; Middle | 1981 |
Unmasking of ventricular preexcitation by vagal stimulation or isoproterenol administration.
Topics: Adult; Ajmaline; Amiodarone; Female; Heart Conduction System; Heart Rate; Humans; Isoproterenol; Mal | 1980 |
Effect of drugs in the Wolff-Parkinson-White syndrome. Importance of initial length of effective refractory period of the accessory pathway.
Topics: Accessory Nerve; Adolescent; Adult; Ajmaline; Amiodarone; Child; Female; Heart Block; Humans; Male; | 1980 |
Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
Topics: Adult; Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Benzofurans; Ele | 1980 |
Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias.
Topics: Adolescent; Adult; Aged; Amiodarone; Atrial Fibrillation; Benzofurans; Child; Drug Administration Sc | 1980 |
Right praecordial early repolarization pattern occurring with the Wolff-Parkinson-White pattern.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Heart Conduction System; Humans; Male; Midd | 1995 |
[Clinical case of the month. Apropos of a case of amiodarone-induced lung disease].
Topics: Amiodarone; Humans; Male; Middle Aged; Pulmonary Fibrosis; Tomography, X-Ray Computed; Wolff-Parkins | 1995 |
Fetal hypothyroidism as a complication of amiodarone treatment for persistent fetal supraventricular tachycardia.
Topics: Adult; Amiodarone; Digoxin; Female; Fetal Diseases; Humans; Hypothyroidism; Infant, Newborn; Male; P | 1994 |
Acceleration of the ventricular response to atrial flutter by amiodarone in an infant with Wolff-Parkinson-White syndrome.
Topics: Amiodarone; Atrial Flutter; Heart; Humans; Infant, Newborn; Male; Wolff-Parkinson-White Syndrome | 1993 |
Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular N | 1996 |
Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Infusions, Intravenous; Male | 1996 |
Amiodarone-induced epididymitis. Report of 2 cases.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Epididymitis; Humans; Male; Middle | 1996 |
[Circulatory arrest after combined intravenous drugs for the treatment of orthodromic circular tachycardia of Wolff-Parkinson-White syndrome].
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Female; Heart Arrest; Humans; Middle | 1997 |
[Use of transesophageal left atrial cardiac pacing for assessment of cordarone effectiveness in patients with atrioventricular tachycardia].
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Drug Administration Schedule; | 1998 |
Effect of intravenous amiodarone on electrophysiologic variables and on the modes of termination of atrioventricular reciprocating tachycardia in Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Female; Heart Conduction System; Humans | 1999 |
Dual-demand pacing for refractory atrioventricular re-entry tachycardia.
Topics: Adult; Amiodarone; Electrocardiography; Female; Follow-Up Studies; Heart Conduction System; Heart Ve | 1979 |
Newer antiarrhythmic drugs.
Topics: Administration, Oral; Adult; Amiodarone; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Ca | 1978 |
Effects of amiodarone studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia.
Topics: Adolescent; Adult; Aged; Amiodarone; Atrial Fibrillation; Atrioventricular Node; Benzofurans; Cardia | 1978 |
[Action and adverse effects of amiodarone in Wolff-Parkinson-White syndrome].
Topics: Aged; Amiodarone; Benzofurans; Bradycardia; Female; Heart Rate; Humans; Tachycardia, Paroxysmal; Wol | 1979 |
Identical twins with differing forms of ventricular pre-excitation.
Topics: Amiodarone; Child; Diseases in Twins; Electrocardiography; Female; Heart; Heart Conduction System; H | 1978 |
Atrial fibrillation complicating Wolff-Parkinson-White syndrome treated with amiodarone.
Topics: Aged; Amiodarone; Atrial Fibrillation; Benzofurans; Electrocardiography; Humans; Male; Wolff-Parkins | 1977 |
Existence of automaticity in anomalous bundle of Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Ajmaline; Amiodarone; Electrocardiography; Female; Heart Conduction System; Human | 1978 |
[Wolff-Parkinson-White syndrome associated with morphology of complete left bundle branch block in a person with patent ductus arteriosus].
Topics: Amiodarone; Bundle of His; Bundle-Branch Block; Ductus Arteriosus, Patent; Electrocardiography; Hear | 1978 |
[The control of the atrio-ventricular reciprocating tachyarrhythmias. A preliminary electrophysiological study and comparison between amiodarone and verapamil (author's transl)].
Topics: Adult; Aged; Amiodarone; Benzofurans; Drug Evaluation; Female; Humans; Male; Middle Aged; Tachycardi | 1978 |
Effect of amiodarone in the Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Amiodarone; Atrial Fibrillation; Atrioventricular Node; Benzofurans; Electrocardi | 1976 |
The occurrence of phase-4 block in the anomalous bundle of patients with Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adult; Ajmaline; Amiodarone; Electrocardiography; Female; Heart Conduction System; Heart | 1975 |
Delayed ventricular repolarization as an anti-arrhythmic principle.
Topics: Adrenergic beta-Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bund | 1985 |
The usefulness of amiodarone in management of refractory supraventricular tachyarrhythmias.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Atrial Fibrillation; Chronic Disease; Female; Humans; Ma | 1989 |
[Wolff-Parkinson-White syndrome and anesthesia].
Topics: Adult; Amiodarone; Anesthesia, General; Female; Flecainide; Humans; Propranolol; Tachycardia, Paroxy | 1987 |
Amiodarone and optic neuropathy.
Topics: Amiodarone; Female; Fluorescein Angiography; Humans; Male; Middle Aged; Optic Nerve Diseases; Vision | 1988 |
Clinical and electrophysiologic effects of amiodarone in patients with atrial fibrillation complicating the Wolff-Parkinson-White syndrome.
Topics: Adult; Amiodarone; Atrial Fibrillation; Child; Electrophysiology; Female; Heart Atria; Heart Conduct | 1988 |
Congenital hypothyroid goiter and amiodarone.
Topics: Adult; Amiodarone; Congenital Hypothyroidism; Female; Goiter; Humans; Hypothyroidism; Infant; Infant | 1988 |
[Possible danger of rapid intravenous amiodarone in re-entry tachycardia in subjects with Wolff-Parkinson-White syndrome].
Topics: Adult; Amiodarone; Electrocardiography; Female; Humans; Injections, Intravenous; Tachycardia, Paroxy | 1986 |
Granular cells as a marker of early amiodarone hepatotoxicity: a pathological and analytical study.
Topics: Amiodarone; Chemical and Drug Induced Liver Injury; Cytoplasmic Granules; Female; Humans; Iodine; Li | 1987 |
Enhanced accessory pathway conduction following intravenous amiodarone in atrial fibrillation. A case report.
Topics: Amiodarone; Atrial Fibrillation; Female; Heart Conduction System; Heart Rate; Humans; Middle Aged; W | 1987 |
Malignant ventricular arrhythmia in the Wolff-Parkinson-White syndrome during amiodarone treatment.
Topics: Adult; Amiodarone; Atrioventricular Node; Cardiac Pacing, Artificial; Electrophysiology; Heart Condu | 1987 |
Amiodarone treatment in cardiac preexcitation syndrome: use of signal averaged electrocardiogram.
Topics: Adolescent; Adult; Amiodarone; Electrocardiography; Humans; Middle Aged; Wolff-Parkinson-White Syndr | 1987 |
[Importance of retrograde occult conduction on the modulation of the ventricular response in the cardiac pre-excitation syndrome].
Topics: Adult; Amiodarone; Electric Countershock; Electric Stimulation; Heart Conduction System; Humans; Mal | 1987 |
[How should we treat the Wolff-Parkinson-White syndrome].
Topics: Adolescent; Adult; Aged; Amiodarone; Cryosurgery; Digitalis Glycosides; Electrocardiography; Electro | 1986 |
Paroxysmal supraventricular tachycardia in supero-inferior ventricles with intact ventricular septum.
Topics: Amiodarone; Electrocardiography; Female; Heart; Humans; Infant; Radiography; Tachycardia, Paroxysmal | 1987 |
Electrophysiologic effects of amiodarone in tachyarrhythmias.
Topics: Adult; Amiodarone; Atrial Fibrillation; Benzofurans; Electrocardiography; Female; Heart; Humans; Mal | 1985 |
Study of Wolff-Parkinson-White syndrome by transesophageal pacing and assessment of long-term amiodarone therapy.
Topics: Adolescent; Adult; Aged; Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Electrocardiography; E | 1985 |
Intravenous amiodarone in the acute termination of supraventricular arrhythmias.
Topics: Adolescent; Adult; Aged; Amiodarone; Atrial Fibrillation; Atrioventricular Node; Benzofurans; Cardia | 1985 |
Amiodarone in pregnancy.
Topics: Adult; Amiodarone; Atrial Fibrillation; Benzofurans; Electrocardiography; Female; Fetal Blood; Human | 1985 |
Amiodarone-induced hyperthyroidism in a patient with Marfan's syndrome and Wolff-Parkinson-White syndrome.
Topics: Adult; Amiodarone; Benzofurans; Female; Humans; Hyperthyroidism; Marfan Syndrome; Thyroid Function T | 1985 |
Effects of oral amiodarone on rate-dependent changes in refractoriness in patients with Wolff-Parkinson-White syndrome.
Topics: Administration, Oral; Amiodarone; Benzofurans; Cardiac Pacing, Artificial; Electrophysiology; Heart | 1985 |
Fatal hepatic failure and encephalopathy associated with amiodarone therapy.
Topics: Amiodarone; Benzofurans; Biopsy; Child; Female; Hepatic Encephalopathy; Humans; Liver; Reye Syndrome | 1985 |